Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Vormfelde

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Pharmacology and Therapeutics|April 27, 2007
Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugsS V Vormfelde, D Sehrt, M R Toliat, et al.
Clinical Pharmacology and Therapeutics|November 14, 2008
Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9C Sachse-Seeboth, J Pfeil, D Sehrt, et al.
Clinical Pharmacology and Therapeutics|June 19, 2009
The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metforminM V Tzvetkov, S V Vormfelde, D Balen, et al.
Journal of Clinical Pharmacology|September 21, 2001
Pharmacokinetics of cerivastatin in renal impairment are predicted by low serum albumin concentration rather than by low creatinine clearanceS V Vormfelde, W Mück, S M Freudenthaler, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 1, 2003
The role of active metabolites in dihydrocodeine effectsH Schmidt, S V Vormfelde, M Walchner-Bonjean, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Pharmacology and Therapeutics|April 27, 2007
Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugsS V Vormfelde, D Sehrt, M R Toliat, et al.
Clinical Pharmacology and Therapeutics|November 14, 2008
Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9C Sachse-Seeboth, J Pfeil, D Sehrt, et al.
Clinical Pharmacology and Therapeutics|June 19, 2009
The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metforminM V Tzvetkov, S V Vormfelde, D Balen, et al.
Journal of Clinical Pharmacology|September 21, 2001
Pharmacokinetics of cerivastatin in renal impairment are predicted by low serum albumin concentration rather than by low creatinine clearanceS V Vormfelde, W Mück, S M Freudenthaler, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 1, 2003
The role of active metabolites in dihydrocodeine effectsH Schmidt, S V Vormfelde, M Walchner-Bonjean, et al.
Pageof 2